Tyrphostin AG 879强烈抑制 HER2/ErbB2,IC50为1 μM,对 ErbB2 的选择性是 PDGFR 和 EGFR 的100倍和500倍。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | HER2 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Poziotinib |
++++
HER2, IC50: 5.3 nM |
98% | |||||||||||||||||
| Tyrphostin AG 879 |
+
HER2-Neu, IC50: 1.0 μM |
95% | |||||||||||||||||
| TAK-285 |
+
HER2, IC50: 17 nM |
99%+ | |||||||||||||||||
| ARRY-380 analog | ✔ | 99% | |||||||||||||||||
| Canertinib |
+++
ErbB2, IC50: 9.0 nM |
EGFR | 99%+ | ||||||||||||||||
| (E/Z)-CP-724714 |
++
HER2/ErbB2, IC50: 10 nM |
95% | |||||||||||||||||
| Lapatinib |
+++
ErbB2, IC50: 9.2 nM |
EGFR | 98% | ||||||||||||||||
| AEE788 |
++++
HER2/ErbB2, IC50: 6 nM |
EGFR | 98+% | ||||||||||||||||
| Neratinib |
+
HER2, IC50: 59 nM |
Src,EGFR | 98% | ||||||||||||||||
| BMS-599626 |
+
HER2, IC50: 30 nM |
98% | |||||||||||||||||
| Mubritinib |
++++
HER2/ErbB2, IC50: 6.0 nM |
99%+ | |||||||||||||||||
| Tucatinib |
+++
ErbB2, IC50: 8 nM |
98% | |||||||||||||||||
| Sapitinib |
++++
ErbB2, IC50: 3 nM |
EGFR | 99%+ | ||||||||||||||||
| CUDC-101 |
++
HER2, IC50: 15.7 nM |
EGFR,HDAC | 99%+ | ||||||||||||||||
| Afatinib dimaleate |
++
HER2, IC50: 14 nM |
98% | |||||||||||||||||
| Afatinib |
++
HER2, IC50: 14 nM |
99% | |||||||||||||||||
| Pertuzumab | ✔ | 95% | |||||||||||||||||
| Trastuzumab | ✔ | 99% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Human epidermal growth factor receptor (EGFR; HER1,erbB1), human epidermal growth factor r eceptor 2 (HER2; erbB2), HER3 (erbB3) and HER4 (erbB4) are members of the ErbB family of transmembrane receptor tyrosine kinases. Among them, HER2 is a validated and high-value target. Approximately 30% of breast cancers have an amplification of the HER2/neu gene or overexpression of its protein product, HER2. Also, overexpression of HER2 occurs in gastric, colorectal, NSCLC and ovarian cancers. Tyrphostin AG 879 is a dual HER2 and Trk inhibitor with IC50 values of 1μM and 10μM, respectively[1]. Treatment with 100μM Tyrphostin AG879 in PC12 cells showed inhibition of Trk-A phosphorylation[2]. Exposure to 20μM Tyrphostin AG 879 for 24h led to decreased phosphorylation of ERK-1 and 2 and decreased protein levels of RAF-1 and HER-2 in MCF-7 cells. Tyrphostin AG 879 at concentration<20μM dose-dependently reduced cell growth of MCF-7, MDA-MB-231 and SK-BR-3 cells[3]. Blocking Trk in vivo by ICV infusions of Tyrphostin AG879 (10μl, 0.5mM in DMSO 10% (V/V) in PBS) impaired both short-term and long-term recognition memory[4]. |
| Concentration | Treated Time | Description | References | |
| Human osteosarcoma U2OS cells | 50 µg/mL | 4 hours | Inhibition of antibody secretion | Cells. 2023 Jun 16;12(12):1642. |
| Rat ovarian cells | >4 µM | 10 days | Inhibition of NTRK3 receptor signaling, resulting in oocyte death and a significant reduction in follicle pool size. | Reproduction. 2009 Oct;138(4):697-707. |
| HEK293 cells | 5 µM | 12 and 24 hours | AG879 inhibits ErbB4 kinase activity, reducing the stability of PSD-95 protein | J Neurosci. 2011 Jan 5;31(1):15-25. |
| A549 cells | 10 µM | 18 hours | Test the inhibitory effect of AG879 on different influenza virus strains, results showed AG879 significantly reduced virus yield. | J Virol. 2011 Mar;85(6):2818-27. |
| SK-BR-3 cells | 0.4-20 µM | 24-46 hours | AG 879 significantly inhibited the proliferation of SK-BR-3 cells by inhibiting the expression of RAF-1 and HER-2, thereby inhibiting the activation of the MAPK signaling pathway. | Cell Mol Life Sci. 2004 Oct;61(19-20):2624-31. |
| MDA-MB-231 cells | 0.4-20 µM | 24-46 hours | AG 879 significantly inhibited the proliferation of MDA-MB-231 cells by inhibiting the expression of RAF-1 and HER-2, thereby inhibiting the activation of the MAPK signaling pathway. | Cell Mol Life Sci. 2004 Oct;61(19-20):2624-31. |
| MCF-7 cells | 0.4-20 µM | 24-46 hours | AG 879 significantly inhibited the proliferation of MCF-7 cells by inhibiting the expression of RAF-1 and HER-2, thereby inhibiting the activation of the MAPK signaling pathway. | Cell Mol Life Sci. 2004 Oct;61(19-20):2624-31. |
| Rat cortical neurons | 10 µM | 30 min | Inhibited Trk receptors, blocking H C-TeTx-induced phosphorylation of Akt, MEK-1/2, ERK-1/2, and p90Rsk | Biochem J. 2003 Jul 15;373(Pt 2):613-20. |
| Rat sensory neurons | 30 µM | 30 minutes | To investigate the effect of AG879 on BDNF-induced sensitization of sensory neurons, results showed that pretreatment with AG879 did not affect the sensitizing action of BDNF. | J Physiol. 2008 Jul 1;586(13):3113-27. |
| GABAergic interneurons | 5 µM | 4 hours | AG879 inhibits ErbB4 kinase activity, leading to increased PSD-95 protein degradation and reduced number and size of PSD-95 puncta | J Neurosci. 2011 Jan 5;31(1):15-25. |
| MDCK cells | 10 µM | 48 hours | Evaluate the effect of AG879 on influenza virus replication, results showed AG879 significantly inhibited viral gene expression and virus yield. | J Virol. 2011 Mar;85(6):2818-27. |
| CHO-K1 cells | 3, 10, 20 µM | 5-7 minutes | Investigated the effect of AG879 on Kv4.2/KChIP2 channels, found AG879 significantly accelerated the inactivation rate and showed use-dependent block. | Br J Pharmacol. 2015 Jul;172(13):3370-82. |
| Hippocampal neurons | 20 µM | Studied the effect of AG879 on A-type potassium currents in hippocampal neurons, found AG879 significantly inhibited A-type potassium currents. | Br J Pharmacol. 2015 Jul;172(13):3370-82. | |
| Administration | Dosage | Frequency | Description | References | ||
| Rat | Neonatal rats | Subcutaneous injection | 7.6 mg/kg/day (5-day old rats) and 6.7 mg/kg/day (25-day old rats) | Once daily for 5 days | Inhibition of NTRK3 receptor signaling in vivo, no significant changes in follicle development rates or oocyte death were observed. | Reproduction. 2009 Oct;138(4):697-707. |
| BALB/c mice | Influenza A/PR8 virus infection model | Intraperitoneal injection | 5 mg/kg | Once daily for 5 days | Evaluate the antiviral activity of AG879 in a mouse model of influenza virus infection, results showed significant reduction in viral replication and mortality | Antimicrob Agents Chemother. 2011 Dec;55(12):5553-9 |
| Dose | Mice: 5 mg/kg[5] (i.p.), 100 mg/kg[6] (s.c.); rat[7] (s.c.): 6.7 mg/kg | ||||||||||
| Administration | i.p., s.c. | ||||||||||
| Pharmacokinetics |
|
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.16mL 0.63mL 0.32mL |
15.80mL 3.16mL 1.58mL |
31.60mL 6.32mL 3.16mL |
|
| CAS号 | 148741-30-4 |
| 分子式 | C18H24N2OS |
| 分子量 | 316.46 |
| SMILES Code | S=C(N)/C(C#N)=C/C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 |
| MDL No. | MFCD00236450 |
| 别名 | AG 879 |
| 运输 | 蓝冰 |
| InChI Key | XRZYELWZLNAXGE-KPKJPENVSA-N |
| Pubchem ID | 135419190 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 50 mg/mL(158 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
沪公网安备 31011702889066号
沪ICP备2024050318号-1